- Home
- NEO vs PDO Comparison
NEO vs PDO Comparison
Compare NEO & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEO | PDO |
|---|---|---|
| Founded | 2001 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | NEO | PDO |
|---|---|---|
| Price | $13.05 | $13.97 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $11.38 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 520.0K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $709,162,000.00 | N/A |
| Revenue This Year | $10.87 | N/A |
| Revenue Next Year | $9.84 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.10 | N/A |
| 52 Week Low | $4.72 | $10.65 |
| 52 Week High | $16.18 | $13.31 |
Technical Indicators
Market Signals| Indicator | NEO | PDO |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 53.58 |
| Support Level | $11.93 | $13.94 |
| Resistance Level | $13.74 | $14.10 |
| Average True Range (ATR) | 0.59 | 0.07 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 69.46 | 56.33 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.